Get the Stockscreener App
0.4998
15.11%
0.0656
After Hours:
.48
-0.0198
-3.96%
Actuate Therapeutics Inc Stock (ACTU) Forecast
The Actuate Therapeutics Inc (ACTU) stock price forecast for the next 30 days is generally negative, with an average analyst price target of $0.3134, representing a -37.30% decrease from the current price of $0.4998. The highest analyst price target is $0.501, and the lowest is $0.1257.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month ACTU Price Target
Average 3.3254
(+565.34% Upside)
Is Actuate Therapeutics Inc (ACTU) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 34.25 | Neutral |
| STOCH(9,6) | 10.07 | Buy |
| STOCHRSI(14) | 29.46 | Neutral |
| MACD(12,26) | -0.1532 | Sell |
| ADX(14) | 23.91 | Neutral |
| William %R | -83.67 | Buy |
| CCI(14) | -107.97 | Sell |
Buy: 2
Sell: 2
Neutral: 3
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
0.6563
Sell
|
0.6139
Sell
|
| MA20 |
0.7191
Sell
|
0.7338
Sell
|
| MA50 |
1.0261
Sell
|
0.9929
Sell
|
| MA100 |
1.3289
Sell
|
1.4508
Sell
|
| MA200 |
2.4642
Sell
|
2.6194
Sell
|
Buy: 0
Sell: 10
Neutral: 0
Summary: Sell
According to our latest analysis, ACTU could be considered a Strong Sell, with 17 technical analysis indicators signaling 2 Buy signals, 12 signaling Sell signals and 3 Neutral signals. This might not be a good time to consider opening new positions on ACTU, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 34.25 indicates that ACTU is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 10.07 indicates that ACTU is oversold. This indicates that ACTU price is at or near the lowest level over a specified lookback period.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 29.46 indicates that ACTU is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- ADX (Average Directional Index): The ADX value of The ADX value of 23.91 suggests that there may be some movement in price, but it lacks strength or conviction.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -107.97 indicates that ACTU is oversold. This means that the price has moved significantly lower than its average, indicating a potential buying opportunity.
Long-term ACTU price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Actuate Therapeutics Inc financial reports and earnings history, Actuate Therapeutics Inc (ACTU) stock could reach $2.2233 by 2030, $24.07 by 2040 and $37.47 by 2050. See the projected annual prices until 2050 of the Actuate Therapeutics Inc stock below:
- Actuate Therapeutics Inc (ACTU) is expected to reach an average price of $12.63 in 2035, with a high prediction of $11.93 and a low estimate of $11.46. This indicates an $2,428% rise from the last recorded price of $0.4998.
- Actuate Therapeutics Inc (ACTU) stock is projected to chart a bullish course in 2040, with an average price target of $23.94, representing an $4,691% surge from its current level. The forecast ranges from a conservative $24.29 to a sky-high $24.07.
- Our analysts predict Actuate Therapeutics Inc (ACTU) to jump 5,830% by 2045, soaring from $30.85 to an average price of $29.64, potentially reaching $32.29. While $30.85 is the low estimate, the potential upside is significant.
- Actuate Therapeutics Inc (ACTU) stock is expected to climb by 2050, reaching an average of $37.34, a $7,370% jump from its current level. However, a wide range of estimates exists, with high and low targets of $37.47 and $36.48, respectively, highlighting the market's uncertainty.
Actuate Therapeutics Inc Stock (ACTU) Year by Year Forecast
Actuate Therapeutics Inc Stock (ACTU) Price Forecast for 2026
The predicted value for Actuate Therapeutics Inc (ACTU) in 2026 is set at an average of $3.5878. Estimates vary from a peak of $7.0499 to a trough of $0.1257, indicating an +617.85% surge from the present price of $0.4998.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| November, 2026 | $1.6277 | $0.1257 | $0.501 | +225.67% |
| December, 2026 | $0.3923 | $0.4923 | $0.8477 | -21.52% |
Actuate Therapeutics Inc Stock (ACTU) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Actuate Therapeutics Inc (ACTU) is $3.3254, with a high forecast of $6.5465 and a low forecast of $0.1043. This indicates an +565.34% increase from the last price of $0.4998.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $1.3532 | $0.1882 | $2.3404 | +170.74% |
| February, 2027 | $1.7886 | $0.6672 | $2.4972 | +257.86% |
| March, 2027 | $1.4753 | $0.4137 | $3.0513 | +195.18% |
| April, 2027 | $2.4207 | $0.8967 | $5.0594 | +384.34% |
| May, 2027 | $0.6475 | $0.2025 | $3.402 | +29.56% |
| June, 2027 | $0.7129 | $0.4202 | $2.2516 | +42.64% |
| July, 2027 | $3.1383 | $0.1043 | $3.5883 | +527.92% |
| August, 2027 | $4.8251 | $2.4424 | $5.8151 | +865.41% |
| September, 2027 | $2.2105 | $2.0105 | $6.5465 | +342.28% |
| October, 2027 | $1.1259 | $0.3019 | $2.1719 | +125.28% |
| November, 2027 | $3.3127 | $0.5787 | $3.7227 | +562.81% |
| December, 2027 | $3.7781 | $2.8754 | $4.7581 | +655.93% |
Actuate Therapeutics Inc Stock (ACTU) Price Forecast for 2028
In 2028, Actuate Therapeutics Inc (ACTU) is projected to reach an average price of $2.202, with a high projection of $4.3962 and a low estimate of $0.00769. This indicates an +340.57% rise from the last price of $0.4998.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $2.8249 | $1.9095 | $4.1495 | +465.21% |
| February, 2028 | $2.7503 | $2.3853 | $4.3962 | +450.28% |
| March, 2028 | $3.9657 | $1.8765 | $4.1227 | +693.46% |
| April, 2028 | $3.0461 | $2.9238 | $4.3584 | +509.47% |
| May, 2028 | $2.1979 | $1.9066 | $3.8151 | +339.76% |
| June, 2028 | $1.2633 | $1.112 | $2.7092 | +152.77% |
| July, 2028 | $0.4099 | $0.014 | $1.6347 | -17.99% |
| August, 2028 | $0.00449 | $0.1022 | $0.5028 | -99.10% |
| September, 2028 | $1.2309 | $0.0131 | $1.3605 | +146.28% |
| October, 2028 | $0.2577 | $0.00769 | $1.3423 | -48.44% |
| November, 2028 | $0.0031 | $0.0404 | $0.6867 | -99.38% |
| December, 2028 | $0.1615 | $0.1442 | $0.5557 | -67.69% |
Actuate Therapeutics Inc Stock (ACTU) Price Forecast for 2029
The 2029 price forecast for Actuate Therapeutics Inc Stock (ACTU) is $4.0746 on average, with a high prediction of $8.0954 and a low estimate of $0.0537. This represents an +715.24% increase from the previous price of $0.4998.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $0.5553 | $0.1374 | $0.9439 | +11.10% |
| February, 2029 | $0.0393 | $0.1098 | $0.8266 | -92.14% |
| March, 2029 | $0.0397 | $0.0537 | $0.3906 | -92.06% |
| April, 2029 | $8.0308 | $8.2075 | $7.8935 | +1,507% |
| May, 2029 | $8.0899 | $8.9081 | $8.0954 | +1,519% |
| June, 2029 | $6.9291 | $6.9591 | $7.9272 | +1,286% |
| July, 2029 | $6.3156 | $5.9891 | $6.5364 | +1,164% |
| August, 2029 | $5.1147 | $6.4529 | $5.0247 | +923.36% |
| September, 2029 | $4.8439 | $5.8158 | $5.2093 | +869.17% |
| October, 2029 | $5.1604 | $4.6369 | $4.8604 | +932.49% |
| November, 2029 | $5.6096 | $5.5673 | $5.155 | +1,022% |
| December, 2029 | $3.746 | $4.436 | $4.6814 | +649.50% |
Actuate Therapeutics Inc Stock (ACTU) Price Forecast for 2030
Actuate Therapeutics Inc Stock (ACTU) is expected to reach an average price of $1.8397 in 2030, with a high forecast of $3.5236 and a low forecast of $0.1558. This signifies an +268.09% surge from the last price of $0.4998.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $0.9052 | $2.3079 | $2.2233 | +81.11% |
| February, 2030 | $1.8044 | $0.5771 | $1.1029 | +261.02% |
| March, 2030 | $4.1635 | $2.4016 | $3.5236 | +733.04% |
| April, 2030 | $2.41 | $3.08 | $3.2821 | +382.19% |
| May, 2030 | $0.8092 | $1.5319 | $2.2073 | +61.90% |
| June, 2030 | $2.0383 | $0.7837 | $1.4883 | +307.83% |
| July, 2030 | $0.5848 | $0.7948 | $1.4169 | +17.01% |
| August, 2030 | $1.664 | $0.9321 | $1.194 | +232.93% |
| September, 2030 | $0.0196 | $0.1558 | $1.1213 | -96.08% |
| October, 2030 | $0.3296 | $0.495 | $0.5803 | -34.05% |
| November, 2030 | $1.5688 | $1.1142 | $0.8338 | +213.88% |
| December, 2030 | $2.8052 | $1.6766 | $2.2564 | +461.27% |
1.49%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):